Sequoia Financial Advisors LLC Increases Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Sequoia Financial Advisors LLC lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,314 shares of the company’s stock after purchasing an additional 303 shares during the period. Sequoia Financial Advisors LLC’s holdings in HealthEquity were worth $1,090,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. International Assets Investment Management LLC purchased a new position in HealthEquity in the 2nd quarter valued at about $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity during the third quarter valued at approximately $39,000. Fidelis Capital Partners LLC acquired a new stake in HealthEquity during the first quarter worth approximately $42,000. GAMMA Investing LLC grew its stake in HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after acquiring an additional 318 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in HealthEquity in the 2nd quarter valued at $73,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Price Performance

HealthEquity stock opened at $88.07 on Friday. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.66 billion, a P/E ratio of 95.73, a PEG ratio of 1.31 and a beta of 0.52. The firm has a fifty day moving average of $80.31 and a 200-day moving average of $79.74. HealthEquity, Inc. has a 52-week low of $61.81 and a 52-week high of $89.23.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The company had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. As a group, analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HQY shares. Bank of America decreased their price objective on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $103.83.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.